Tebit DM - Search Results

1

HIV-1 Group O Origin, Evolution, Pathogenesis, and Treatment: Unraveling the Complexity of an Outlier 25 Years Later.

Bush S, Tebit DM. Bush S, et al. Among authors: tebit dm. AIDS Rev. 2015 Jul-Sep;17(3):147-58. AIDS Rev. 2015. PMID: 26450803 Review.

2

High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.

Etta EM, Mavhandu L, Manhaeve C, McGonigle K, Jackson P, Rekosh D, Hammarskjold ML, Bessong PO, Tebit DM. Etta EM, et al. Among authors: tebit dm. AIDS Res Ther. 2017 Jul 27;14(1):36. doi: 10.1186/s12981-017-0161-z. AIDS Res Ther. 2017. PMID: 28750647 Free PMC article.

3

Drug Resistance Mutations in a Population Before Antiretroviral Therapy Initiation in Northern South Africa.

Ogola B, Matume ND, Mavhandu-Ramarumo LG, Tebit DM, Bessong PO. Ogola B, et al. Among authors: tebit dm. AIDS Res Hum Retroviruses. 2022 Mar;38(3):248-256. doi: 10.1089/AID.2021.0026. Epub 2021 Jul 12. AIDS Res Hum Retroviruses. 2022. PMID: 34107774

4

Rev-RRE Functional Activity Differs Substantially Among Primary HIV-1 Isolates.

Jackson PE, Tebit DM, Rekosh D, Hammarskjold ML. Jackson PE, et al. Among authors: tebit dm. AIDS Res Hum Retroviruses. 2016 Sep;32(9):923-34. doi: 10.1089/AID.2016.0047. Epub 2016 Jun 3. AIDS Res Hum Retroviruses. 2016. PMID: 27147495 Free PMC article.

5

Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage.

Nankya IL, Tebit DM, Abraha A, Kyeyune F, Gibson R, Jegede O, Nickel G, Arts EJ. Nankya IL, et al. Among authors: tebit dm. AIDS Res Ther. 2015 Oct 3;12:34. doi: 10.1186/s12981-015-0066-7. eCollection 2015. AIDS Res Ther. 2015. PMID: 26435727 Free PMC article.

6

HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle?

Tebit DM, Nankya I, Arts EJ, Gao Y. Tebit DM, et al. AIDS Rev. 2007 Apr-Jun;9(2):75-87. AIDS Rev. 2007. PMID: 17694675 Review.

7

HIV-1 subtype C predicted co-receptor tropism in Africa: an individual sequence level meta-analysis.

Matume ND, Tebit DM, Bessong PO. Matume ND, et al. Among authors: tebit dm. AIDS Res Ther. 2020 Feb 7;17(1):5. doi: 10.1186/s12981-020-0263-x. AIDS Res Ther. 2020. PMID: 32033571 Free PMC article. Review.

8

HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.

Tebit DM, Patel H, Ratcliff A, Alessandri E, Liu J, Carpenter C, Plantier JC, Arts EJ. Tebit DM, et al. AIDS Res Hum Retroviruses. 2016 Jul;32(7):676-88. doi: 10.1089/AID.2015.0318. Epub 2016 Mar 16. AIDS Res Hum Retroviruses. 2016. PMID: 26861573 Free PMC article.

9

Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa.

Matume ND, Tebit DM, Gray LR, Hammarskjold ML, Rekosh D, Bessong PO. Matume ND, et al. Among authors: tebit dm. J Clin Virol. 2018 Jun;103:81-87. doi: 10.1016/j.jcv.2018.02.008. Epub 2018 Feb 15. J Clin Virol. 2018. PMID: 29661652 Free PMC article.

10

Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overview.

Bessong PO, Matume ND, Tebit DM. Bessong PO, et al. Among authors: tebit dm. AIDS Res Ther. 2021 Jan 6;18(1):1. doi: 10.1186/s12981-020-00324-w. AIDS Res Ther. 2021. PMID: 33407664 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters